Tobacco Use: A Global Public Health Problem

Aug.25.2023
Tobacco use remains a global public health issue, particularly affecting young people, says Coordinator of Pulmonology Course.

Tobacco Use Still a Public Health Problem, Says Coordinator of Pulmonology Course

 

According to Dr. Margarita Isabel Cervantes Rodríguez, coordinator of the undergraduate pulmonology course affiliated with the internal medicine module, smoking continues to be a global public health problem, unfortunately affecting young people from an early age with exposure to both tobacco and electronic cigarettes.

 

The pulmonologist explained that, for example, in vaping, unlike cigarette burning, there is no combustion of fuel. However, the quantities of nicotine in electronic cigarettes are higher, as well as the accessibility of these products. They can be easily obtained from kiosks outside certain shopping centers, as well as other stores and gas stations.

 

"In this way, young people are exposed to a highly addictive substance that leads to the consumption of other toxic substances in combination or eventually," such as marijuana, cocaine, and other drugs," she said.

 

She mentioned that there are currently various campaigns to quit tobacco use, which has led to the emergence of electronic cigarettes. "We know that we have more than four thousand known toxic substances, with over 50 of them being carcinogens, and nicotine is the main addictive substance," she added.

 

She reiterated that campaigns have been carried out over the years to quit smoking, such as banning cigarette advertising on television and prohibiting posters that promote smoking. Despite the increase in efforts, consumption continues.

 

Cervantes Rodríguez stated that cigarette packages now display images depicting the consequences of smoking, such as abortion, birth defects, animal extinction, and pollution of the seas and oceans.

 

"To date, we have a cessation plan in place that consists of a treatment that helps the body release dopamine, along with nicotine replacement therapy such as patches. For patients with serious dependencies, we offer a second nicotine replacement with gums or lozenges," she explained.

 

She added that this is not enough; there should also be cognitive-behavioral and psychological support to help people quit smoking because tobacco use is a disease.

 

She emphasized that with these cessation plans, improvements in tobacco abstinence, especially nicotine, have been observed in an eight to 12-week treatment plan, which leads to a high success rate in quitting smoking.

 

Regarding the negative effects of tobacco use, she mentioned dependency, consumption of other substances, and, in some cases, the development of Chronic Obstructive Pulmonary Disease (COPD) and lung cancer, which are among the leading causes of death worldwide. Other effects include diseases in children, environmental pollution, and more.

 

"There is treatment nowadays to quit smoking, and we must not forget that it is not only the person who smokes that is harmed, but also the effects of second and third-hand smoke on those around them," she concluded.

 

We will continue to keep you informed.

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Philip Morris International: When High Valuation Meets Flawed Performance — A 2Firsts Reader Submission
Philip Morris International: When High Valuation Meets Flawed Performance — A 2Firsts Reader Submission
After PMI released its Q2 2025 earnings, a 2Firsts reader submitted an in-depth analysis unpacking key concerns behind the headline numbers. While earnings beat expectations, slowing organic revenue growth, challenges in combustibles and ZYN, and a low margin for error under high valuation have triggered market unease. The next few quarters may prove pivotal for PMI’s growth narrative.
Jul.24
Ireland to Ban Flavored E-Cigarettes, Advertising; Industry Warns 220,000 Vapers at Risk
Ireland to Ban Flavored E-Cigarettes, Advertising; Industry Warns 220,000 Vapers at Risk
Ireland plans to ban flavored e-cigarettes, introduce plain packaging, and restrict in-store displays and advertising. The Responsible Vaping Ireland group warns the move could harm small businesses and reverse progress in reducing smoking. Since 2015, over 225,000 adults have quit smoking with e-cigarettes, making up nearly a quarter of quitters in 2023.
Jun.03 by 2FIRSTS.ai
Russia's State Duma to Ban E-Cigarette Sales Pending Legislative Proposal
Russia's State Duma to Ban E-Cigarette Sales Pending Legislative Proposal
Russia’s State Duma is prepared to support a full ban on e-cigarettes if the proposal comes from the government. Industry and Trade Minister Anton Alikhanov has voiced support, calling for a complete ban. Lawmakers have already drafted a bill targeting the circulation and production of e-cigarettes and related equipment.
Jun.04 by 2FIRSTS.ai
Japan Tobacco 2025 H1 Financial Report: Net Profit Up 5% YoY to $2.1 Billion, Heated Tobacco Shipments Rise Nearly 30%
Japan Tobacco 2025 H1 Financial Report: Net Profit Up 5% YoY to $2.1 Billion, Heated Tobacco Shipments Rise Nearly 30%
Japan Tobacco's (JT) 2025 H1 financial report shows year-over-year growth in key metrics, driven by pricing strategy, international business integration, and heated tobacco (HTS) expansion. Net revenue reached approximately $11.5 billion, up 10.5% YoY, while net profit rose 4.8% to about $2.1 billion. HTS shipments hit 5 billion units, a 29.5% YoY increase. The newly launched Ploom AURA reached a 13.6% market share in Japan in Q2.
Aug.01 by 2FIRSTS.ai
Smoore's Subsidiary CCELL Faces Antitrust Lawsuit in the U.S., Accused of Price Manipulation and Market Monopoly
Smoore's Subsidiary CCELL Faces Antitrust Lawsuit in the U.S., Accused of Price Manipulation and Market Monopoly
A U.S. federal court in Arizona has recently accepted a class-action lawsuit against Chinese e-cigarette manufacturer Smoore and its U.S. distributor. The suit accuses them of monopolizing the U.S. cannabis vape market through price manipulation and market division, resulting in higher costs for consumers. This marks the second such case filed this year.
Jul.03 by 2FIRSTS.ai
On the Global Tobacco Battlefield: The Clash Between Science and Misinformation — A Tobacco Harm Reduction Expert’s Contribution to 2Firsts
On the Global Tobacco Battlefield: The Clash Between Science and Misinformation — A Tobacco Harm Reduction Expert’s Contribution to 2Firsts
In this in-depth contribution to 2Firsts, harm reduction expert Harry Shapiro exposes the misinformation and bias in global tobacco control, calling for evidence-based safer nicotine alternatives to protect public health and save lives.
Jul.08